Acetyl-CoA carboxylase (ACC) has crucial roles in fatty acid metabolism and is an attractive target for drug discovery against diabetes, cancer and other diseases [1] [2] [3] [4] [5] [6] . Saccharomyces cerevisiae ACC (ScACC) is crucial for the production of very-long-chain fatty acids and the maintenance of the nuclear envelope 7, 8 . ACC contains biotin carboxylase (BC) and carboxyltransferase (CT) activities, and its biotin is linked covalently to the biotin carboxyl carrier protein (BCCP). Most eukaryotic ACCs are 250-kilodalton (kDa), multi-domain enzymes and function as homodimers and higher oligomers. They contain a unique, 80-kDa central region that shares no homology with other proteins. Although the structures of the BC, CT and BCCP domains and other biotin-dependent carboxylase holoenzymes are known 1,9-14 , there is currently no structural information on the ACC holoenzyme. Here we report the crystal structure of the full-length, 500-kDa holoenzyme dimer of ScACC. The structure is remarkably different from that of the other biotin-dependent carboxylases. The central region contains five domains and is important for positioning the BC and CT domains for catalysis. The structure unexpectedly reveals a dimer of the BC domain and extensive conformational differences compared to the structure of the BC domain alone, which is a monomer. These structural changes reveal why the BC domain alone is catalytically inactive and define the molecular mechanism for the inhibition of eukaryotic ACC by the natural product soraphen A 15, 16 and by phosphorylation of a Ser residue just before the BC domain core in mammalian ACC. The BC and CT active sites are separated by 80 Å , and the entire BCCP domain must translocate during catalysis.
. ACC contains biotin carboxylase (BC) and carboxyltransferase (CT) activities, and its biotin is linked covalently to the biotin carboxyl carrier protein (BCCP). Most eukaryotic ACCs are 250-kilodalton (kDa), multi-domain enzymes and function as homodimers and higher oligomers. They contain a unique, 80-kDa central region that shares no homology with other proteins. Although the structures of the BC, CT and BCCP domains and other biotin-dependent carboxylase holoenzymes are known 1, [9] [10] [11] [12] [13] [14] , there is currently no structural information on the ACC holoenzyme. Here we report the crystal structure of the full-length, 500-kDa holoenzyme dimer of ScACC. The structure is remarkably different from that of the other biotin-dependent carboxylases. The central region contains five domains and is important for positioning the BC and CT domains for catalysis. The structure unexpectedly reveals a dimer of the BC domain and extensive conformational differences compared to the structure of the BC domain alone, which is a monomer. These structural changes reveal why the BC domain alone is catalytically inactive and define the molecular mechanism for the inhibition of eukaryotic ACC by the natural product soraphen A 15, 16 and by phosphorylation of a Ser residue just before the BC domain core in mammalian ACC. The BC and CT active sites are separated by 80 Å , and the entire BCCP domain must translocate during catalysis.
The primary sequences of the single-chain, multi-domain eukaryotic ACCs can be divided into three regions of roughly equal sizes. The amino-terminal region (residues 1-795 in ScACC, Fig. 1a ) contains the BC and BCCP domains, with possibly a BT (BC-CT interaction) domain between them, as observed in the structures of propionylCoA carboxylase (PCC) 11 and 3-methylcrotonyl-CoA carboxylase (MCC) 12 . The carboxy-terminal region (residues 1492-2233) contains the N and C domains of CT 17 . The structure and function of the central region (residues 796-1491) are currently not known. It is not as well conserved among the eukaryotic ACCs (Extended Data Figs 1-3) . BC catalyses the MgATP-dependent carboxylation of the N19 atom of biotin (Extended Data Fig. 4 ). The carboxybiotin (and BCCP) then translocates to the CT active site, where the substrate acetyl-CoA is carboxylated.
We expressed in Escherichia coli the 250-kDa ScACC (residues 22-2233) and determined its crystal structure at 3.2 Å resolution (Extended Data Table 1, Extended Data Fig. 4 ). The structure of the ScACC holoenzyme is remarkably different from that of the other biotin-dependent carboxylases [9] [10] [11] [12] [13] [14] . The 500-kDa holoenzyme dimer obeys two-fold symmetry, and its overall structure is shaped like a quarter of a disk (Fig. 1b) , with a radius of ,140 Å and thickness of ,120 Å (Fig. 1c) , although there is a large channel measuring ,30 Å across through the centre of the holoenzyme (Extended Data  Fig. 5) . A BC domain dimer (Fig. 1d) is located near the centre of the disk, while the CT domain dimer (Fig. 1e ) forms a part of the edge of the disk. A BCCP domain is positioned near the centre of each face of the holoenzyme, and its biotin is located in the CT active site (Fig. 1b) .
We have also determined the structure at 3.1 Å resolution of the holoenzyme where the BCCP domain is not biotinylated (Extended Data Table 1 ). The overall structure of this dimer is essentially the same as the other structure, with r.m.s. distance of 0.45 Å for their 3,928 equivalent Ca atoms, although the BCCP domain is disordered in the absence of biotinylation. Earlier studies showed that biotinylation stabilizes E. coli BCCP 18, 19 . This structure of the holoenzyme will not be discussed further here.
The overall structures of the two protomers of the holoenzyme are similar, with r.m.s. distance of 1.1 Å for 1,862 equivalent Ca atoms located within 3 Å of each other after superposition. On the other hand, the r.m.s. distance is only 0.76 Å if the CT domains are superposed, and differences in the orientation and position of the other domains are visible, especially for the BC domain, which is located furthest from CT (Extended Data Fig. 4 ). Within CT, conformational differences in the small inserted domain 17 are observed (Extended Data Fig. 5 ), likely to be linked to differences in the position of BCCP in the two protomers, as the insert domain has direct contacts with BCCP.
The structure reveals that the central region of ScACC contains five domains, which we have named ACC central (AC) domains AC1 through AC5, giving a total of 10 major domains for each ScACC protomer (Fig. 1a) . Domains AC1, AC2 and AC3 are all helical (Fig. 1f, Extended Data Fig. 2 ). AC1 contains three pairs of anti-parallel helices as well as inserts of a four-helical bundle (domain AC2, helices a3-a6) and a helical hairpin (a8-a9, Extended Data Fig. 5 ). AC3 is also a four-helical bundle but it has no interactions with AC1 and AC2, and instead is positioned between AC4 and AC5, mediating interactions between them. Domain AC4 is located at the end of the disk edge, and is separated from the AC4 domain of the other protomer by ,200 Å (Fig. 1b) . Unexpectedly, the structure shows that AC4 and AC5 have similar backbone folds, consisting of a twisted b-sheet flanked on one face by helices (Extended Data Figs 4, 6 ). The r.m.s. distance is 2.9 Å for their equivalent Ca atoms, but the sequence identity is only 12%. This backbone fold has weak similarity to a part of formamidase 20 (Extended Data Fig. 6 ) and several other enzymes, but the Z score is below 6.5 and the sequence identity is less than 9% 21 . The active sites of these enzymes are not conserved in AC4 or AC5. Therefore, this structural similarity is unlikely to have any functional significance for ACC.
The structure confirms the presence of a BT domain in the N-terminal region of ScACC (Fig. 1a) . Its structure is similar to that in PCC 11 , with a central, long helix (Extended Data Fig. 4 ) surrounded by an eight-stranded anti-parallel b-barrel (Extended Data Fig. 5 ). The domain helps to mediate interactions between the BC and CT domains, as there are no direct contacts between them in the holoenzyme (Fig. 1b) . Within each protomer, the last three strands of the BT domain b-barrel (b27-b29) faces the BC domain (Figs 1b, 2a) , while the C-terminal end of the long helix and the following loop connecting to the first strand (the hook 11 ) is flanked by the helical hairpin insert of AC1 (a8-a9) on one side and an inserted segment of a long loop between two b-strands (b4A and b4B) in the C domain of CT on the other side (Fig. 2b, Extended Data Fig. 4 ). In addition, a part of the long linker between the BCCP and AC1 domains has hydrophobic interactions with the top of one side of the BT domain b-barrel (Fig. 1b,  Extended Data Fig. 5 ).
A total of ,9,000 Å 2 of the surface area of each protomer is buried in the dimer interface, predominantly from the BC (1,200 Å other protomer, but it is expected to translocate to the BC active site during catalysis (see later). A major surprise from the structure is the observation of a BC domain dimer (Fig. 1d) , because the BC domain alone is consistently a monomer and catalytically inactive based on earlier studies 15, 16, 22, 23 . Moreover, the organization of this BC domain dimer is similar to that of the BC subunit dimer of E. coli ACC [24] [25] [26] (Fig. 3a) , with a mostly hydrophilic interface (Extended Data Fig. 7) . However, the structure of BC domain alone is incompatible with such a dimer due to steric clashes between the two molecules 16 (Extended Data Fig. 7 ). Large conformational changes for residues in the dimer interface are therefore necessary for the formation of this dimer, primarily involving the b-strands and connecting loops in the C sub-domain of BC (Fig. 3b) . Especially, strand b18 moves by ,8 Å , taking it out of the central b-sheet of the C-domain (Fig. 3c, Supplementary Video 1) . b18 instead forms a b-sheet with a new strand, b21, which is not present in the structure of BC domain alone. Residues in the b17-b18 loop move by up to 20 Å , and those in the b18-b19 loop by up to 7 Å (Fig. 3c ). In addition, the main chain of neighbouring strands b17, b19 and b20 shifts by ,3 Å . The new b18-loop-b19 structure is in the centre of the BC domain dimer (Fig. 3a) , where the tip of this loop contacts the side chain of Trp487 in the other protomer (Extended Data Fig. 7 ).
The two distinct conformations of this domain explain why it is catalytically inactive on its own 15 and also define the molecular mechanism for the inhibition of eukaryotic ACC by the natural product soraphen A 16 and by phosphorylation of a Ser residue just before the BC domain core in mammalian ACC (Ser80 in human ACC1 and Ser222 in ACC2) 23 (Extended Data Fig. 1 ). As a part of the conformational change, residues in the b19-b20 loop move by up to 10 Å (Fig. 3d, Supplementary Video  2) . This loop in the structure of BC domain alone is likely to interfere with the binding of BCCP-biotin (Fig. 3d, Extended Data Fig. 7 ), based on the binding mode of biotin to E. coli BC 26 . Consequently, BC domain alone is catalytically inactive because it assumes a conformation that cannot bind the BCCP-biotin substrate.
Soraphen A recognizes the conformation of isolated BC domain 16 , and this binding site does not exist in the BC domain dimer in the holoenzyme owing to the structural changes (Fig. 3c ). For example, strands b19 and b20 move into the binding site, and especially the side . The two molecules at the top are superposed, and the two molecules at the bottom have ,12u difference in orientation. b, Overlay of the BC domain of ScACC holoenzyme (in red) with the BC domain alone (in grey) in complex with soraphen A (green, labelled Sor) 16 . The region of large conformational differences is highlighted in light blue. The view is the same as in a. c, Detailed view of the conformational changes in the dimer interface. Blue arrows indicate some of the changes from the BC domain alone (grey) to the BC domain in the holoenzyme (red). d, Conformational changes near the biotin binding site, especially the b19-b20 loop. This is coupled to changes in the b2 to aF segment. A possible hydrogen bond between the amide linkage of biotin and the b19-b20 loop is indicated with the dashed lines (red). e, A model for how conformational transitions in the dimer interface affect catalysis and dimerization of the eukaryotic BC domain, updated from an earlier model 25 . Biotin is shown as the fused black pentagons, while soraphen A and phosphorylated serine are indicated by Sor and P, respectively. Bacterial BC subunit does not undergo the conformational transition, and its monomers can be catalytically active 25 .
LETTER RESEARCH chain of Trp487 (b19) is in direct clash with soraphen A (Fig. 3c,  Extended Data Fig. 7) . Therefore, soraphen A inhibits the enzyme allosterically by stabilizing a catalytically inactive conformation of the BC domain. In the context of the holoenzyme, soraphen A binding will disrupt the formation of BC domain dimer (Fig. 1d) , as the other protomer clashes with the compound as well (Extended Data Fig. 7 ). This could also be detrimental for catalysis as the BC domains may not be positioned correctly to accept the BCCP-biotin for carboxylation.
Upon phosphorylation, the peptide segment containing pSer222 of human ACC2 is located in the same binding site as soraphen A 23 , and the Trp487 side chain in the holoenzyme structure also clashes with this segment (Extended Data Fig. 7) . Therefore, phosphorylation of this Ser residue inhibits the enzyme through the same mechanism as that of soraphen A. These structural observations greatly extend a model for the inhibitory mechanism proposed earlier 25 (Fig. 3e ). ScACC does not have an equivalent phosphorylation site in this region of the sequence.
In comparison, the structure of the CT domain dimer in the holoenzyme is essentially the same as that of the domain alone 17 , with r.m.s. distance of 0.61 Å among their equivalent Ca atoms (Extended Data  Fig. 8 ). The binding of both BCCP-biotin and CoA (Extended Data  Fig. 4) in one of the CT active sites provides direct insights into the catalysis by this enzyme. The thiol group of CoA is 4.3 Å away from the N19 atom of biotin (Extended Data Fig. 8) . Therefore, the two substrates are likely to be in the correct positions for catalysis. The position of biotin clashes with that of the compound CP-640186 (Extended Data Fig. 8) , a nanomolar inhibitor of mammalian ACCs 27 , confirming that it functions by blocking biotin binding to the CT active site 28 .
Prior to the structure determination of the holoenzyme, we obtained the crystal structures for residues 797-1033 (domains AC1-AC2), 1036-1503 (AC3-AC5), and 569-1494 (BT, BCCP and the entire central region) (Extended Data Table 1 ). Comparisons of the structures of these domains alone with that of the holoenzyme reveal substantial variability in the relative positioning of the domains. Domains AC3-AC4 in the structure of AC3-AC5 alone can be readily superposed with those in the holoenzyme, but then the orientation of domain AC5 differ by 40u (Extended Data Fig. 9 ). Even more variability is observed in the structure of BT-BCCP-AC1-AC5 alone, illustrated by the differences in the positioning of AC1-AC2 relative to the BT domain and AC3-AC5 (Extended Data Fig. 9 ). Interestingly, between the two unique copies of the BT-BCCP-AC1-AC5 molecule in the crystal, one has a conformation of AC3-AC5 that is very similar to that in the holoenzyme (Extended Data Fig. 9 ), while the other is similar to that in AC3-AC5 alone, suggesting that domains AC3-AC5 may assume two (or more) distinct conformations.
Another discovery from the structure is that the central region has minimal contributions to the formation of the dimer. Besides the ,300 Å 2 surface area burial for AC1 and AC2 (Fig. 2c) , the central region has no contacts with the other protomer (Fig. 1b) . On the other hand, the structure suggests that the central region is important for maintaining the BC and CT dimers in the correct relative positions for catalysis. The CT domain dimer is sandwiched by AC5 on both sides (Fig. 1e) . The BT and AC2 domains of the two protomers form a platform, keeping the BC domain dimer in place and possibly also helping with BC domain dimerization (Fig. 1b) . The conformational variability observed for the domains in the central region (Extended Data Fig. 9 ) might have a role in regulating the activity of the holoenzyme.
The structural analysis indicates that BCCP-biotin becomes carboxylated in the BC active site of its own protomer, and then translocates to the CT active site at the dimer interface, where it contacts the C domain of the other protomer (Fig. 4) . The distance between the BC and CT active sites is ,80 Å , indicating that the entire BCCP domain must translocate during catalysis (swinging-domain model, Extended Data Fig. 4) , as has been observed in the other holoenzymes 1, [9] [10] [11] [12] [13] [14] . In fact, the linker from BT to BCCP (residues 697-700) is about 45 Å from the N19 atom of biotin, and therefore a rotation of this linker by ,180u could bring the biotin into the BC active site from the CT active site (Fig. 4) . The linker from BCCP to AC1 (residues 770-795) is much longer and can accommodate such a rotation, and part of this linker is disordered in the current structure.
We introduced mutations in the interfaces in the holoenzyme to assess the structural information. The mutants that could be purified migrated at the same position on a gel filtration column and had nearly the same thermal melting curves as the wild-type enzyme (data not shown). Deletion of the a-helical hairpin (a8-a9, residues 940-972) in domain AC1 (Extended Data Fig. 2) or the b4A-b4B loop in the C domain of CT (residues 1902-1916, Extended Data Fig. 3 ) abolished the catalytic activity (Table 1) , demonstrating their importance in anchoring the hook of the BT domain (Fig. 2b) . On the other hand, mutating Gln608 in the hook, which interacts with the main chain of the b4A-b4B loop (Fig. 2b) , had little effect on catalysis. Similarly, the R656E mutation at the edge of the BT-BC interface (Fig. 2a) had little effect, suggesting that these single-site mutations are not sufficient to disrupt the holoenzyme or that these regions of contact do not contribute significantly to the interactions. We introduced the K73E, R76E and W487A mutations in the BC domain dimer interface (Extended Data Fig. 7) , and all three essentially abolished the catalytic activity ( Table 1 ). The mutations probably disrupted the BC domain dimer, and the domain changed to the other conformation that is incompatible with catalysis. The K73E and R76E mutants are equivalent to the R16E and R19E mutants of E. coli BC subunit that we characterized earlier 25, 29 . Those mutations greatly destabilized the dimer, but had only a small effect (about three-fold) on the catalytic activity of the BC subunit alone, probably because the E. coli BC monomer does not undergo the conformational transition as observed here for the eukaryotic BC (Fig. 3e) . However, the R19E mutation had a much larger effect in vivo, probably in the context of the E. coli ACC holoenzyme 30 . Overall, our studies have produced the first structural information on the 500-kDa yeast ACC holoenzyme dimer. This structure is likely to have relevance for other eukaryotic ACCs, especially the human ACC holoenzymes, as they share 45% sequence identity with yeast ACC. The structures of the BC and CT domains of human and yeast ACCs are highly similar and consistent with their strong sequence conservation (Extended Data Figs 1, 3) . Although the sequence conservation for the central region is weaker, the secondary structure elements in yeast ACC are predicted to be present in human ACC as well, and residues in these secondary structure elements are more conserved than those in the loops (Extended Data Fig. 2) . Therefore, the overall structure of human ACC holoenzyme is likely to be similar to that of yeast ACC.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Protein expression and purification. The N-terminal segment of the central region of Saccharomyces cerevisiae ACC (ScACC, gene ACC1, residues 797-1033, AC1-AC2 domains) was expressed at 20 uC in E. coli BL21(DE3) Star cells for native protein or B384(DE3) cells for selenomethionyl protein, in the presence of a chaperone plasmid pG-KJE8 (TaKaRa). The recombinant protein carried a C-terminal His-tag and was purified by Ni-NTA (Qiagen) and gel filtration chromatography (Sephacryl S-300, GE Healthcare) in buffer A (20 mM Tris (pH 7.5), 300 mM NaCl, and 2 mM DTT).
The C-terminal segment of the central region of ScACC (residues 1036-1503, AC3-AC5 domains) was expressed in E. coli B834(DE3) cells at 25 uC for selenomethionyl protein and purified following the same protocol. The gel filtration buffer contained 10 mM rather than 2 mM DTT.
The segment containing the BT-BCCP-AC1-AC5 domains of ScACC (residues 569-1494) was expressed in BL21(DE3) Rosetta cells at 24 uC. The recombinant protein, with a C-terminal His-tag, was purified by Ni-NTA and gel filtration chromatography in buffer A.
Full-length ScACC (residues 1-2233) was constructed into pET28a (Novagen) by sewing together two PCR fragments with a 900-nt overlap. For structure determination, the segment containing residues 22-2233, with a C-terminal His-tag, was expressed in E. coli BL21(DE3) Star cells at 25 uC. Protein expression for all the different ScACC segments was driven by the trp promoter and was induced with 3-indoleacrylic acid. However, the endogenous E. coli biotin-protein ligase (BPL, also known as BirA) was not able to biotinylate the ScACC. The ScBPL gene was amplified from the genome and inserted into the pCDFDuet-1 vector (Novagen) multiple cloning site 2 without any affinity tag. Co-expression of ScBPL and the inclusion of 20 mg l 21 biotin in the media allowed complete biotinylation of ScACC, confirmed by an avidin shift assay. The protein was purified by Ni-NTA and gel filtration chromatography in buffer A. Typically 0.5 mg of biotinylated ScACC (or 3 mg of unbiotinylated ScACC) could be purified from 12 l of culture. Protein crystallization. Crystals were obtained at 20 uC using the sitting-drop vapour diffusion method. Native and selenomethionyl crystals of the AC1-AC2 domains were obtained using a precipitant solution of 90 mM Bis-tris propane and 60 mM citric acid (pH 6.4), and 20% (w/v) PEG3350. The protein concentration was 12 mg ml 21 , and the crystals took 3 weeks to reach full size. Selenomethionine-substituted crystals of the AC3-AC5 domains were obtained after 2 days. The protein concentration was 3.6 mg ml
21
, and the precipitant solution contained 80 mM HEPES (pH 7.5), 4% (v/v) MPD, 8 mM sodium citrate, 4% (v/v) glycerol, and 40 mM NDSB-201.
Native crystals of the BT-BCCP-AC1-AC5 domains were obtained after 4 days. The protein concentration was 15 mg ml 21 , and the precipitant solution contained 80 mM HEPES (pH 7.5), 9.6% (w/v) PEG6000, 1.6% (v/v) MPD, 60 mM sodium citrate, and 80 mM NaI.
Full-length ACC protein was incubated with 3.3 mM acetyl-CoA and 3.3 mM Mg-ADP for 30 min on ice before crystallization. Crystals were obtained after 2 weeks. The protein concentration was 5 mg ml 21 , and the precipitant solution contained 14% (w/v) PEG3350, 4% (v/v) tert-butanol, and 0.2 M sodium citrate.
Glycerol was used as the cryo-protectant and all crystals were flash frozen in liquid nitrogen for data collection at 100 K. Data collection and structure determination. X-ray diffraction data of AC1-AC2 domains were collected on an ADSC Q315 CCD at the X29A beamline of the National Synchrotron Light Source (NSLS). The diffraction images were processed with the HKL program 31 . The crystal belonged to space group P6 5 with cell parameters of a 5 b 5 117.6 Å , and c 5 73.8 Å . There is a domain-swapped dimer of the protein in the asymmetric unit. A selenomethionyl single-wavelength anomalous diffraction (SAD) data set was collected to 3.0 Å resolution (wavelength 0.979 Å ) and a native data set to 2.5 Å resolution (wavelength 1.075 Å ). Five Se atoms were located with program Solve 32 and used for phasing with program Phenix 33 . The phase information was then extended to 2.5 Å with solvent flattening, histogram matching and two-fold non-crystallographic symmetry (NCS) averaging using the program DM in CCP4 34 . The atomic model was built into the electron density map manually with the program Coot 35 . Structure refinement was performed with CNS 36 and Refmac5
37
.
A selenomethionyl SAD data set to 3.2 Å resolution of AC3-AC5 domains was collected at the X29A beamline (wavelength 0.979 Å ). The crystal belonged to space group P2 1 , with cell parameters of a 5 56.8 Å , b 5 93.3 Å , c 5 111.1 Å , and b 5 100.6u. There are two molecules in the asymmetric unit. Five Se atoms in each molecule were located and employed for phasing with program Phenix. An atomic model was manually built into the electron density map with program Coot, and the structure was refined with Refmac5.
A native diffraction data set to 3.0 Å resolution of BT-BCCP-AC1-AC5 domains was collected at the X29A beamline (wavelength 1.075 Å ). The crystal belonged to space group P2 1 , with cell parameters of a 5 93.3 Å , b 5 149.7 Å , c 5 95.4 Å , and b 5 118.4u. There is a dimer of the protein in the asymmetric unit. The structures of AC1-AC2 and AC3-AC5 domains were used as the search models to solve the structure by molecular replacement with the program Phaser 38 . The BT and BCCP domains were manually built into the electron density map.
A native diffraction data set to 3.1 Å resolution of residues 22-2233 of unbiotinylated ScACC was collected on a Pilatus 6M detector at the X25 beamline of NSLS (wavelength 1.100 Å ). There is a dimer of ScACC in the asymmetric unit. The structure was solved by molecular replacement with the program Phaser. The structures of AC1-AC2, AC3-AC5, and BT domains reported here and previously published structures of yeast BC 16 and CT domains 17 were used as the search models. However, no electron density for the BCCP domain was observed based on the crystallographic analysis.
A native diffraction data set to 3.2 Å resolution of biotinylated ScACC was collected at the X25 beamline. The crystal belonged to space group P4 3 2 1 2, with cell parameters of a 5 b 5 159.9 Å , and c 5 614.4 Å , isomorphous to that of the unbiotinylated ScACC. The final atomic model was built with Coot and refined with Refmac5. NCS restraints were used during the refinement. Crystals of fulllength ScACC (residues 1-2233) did not diffract beyond 8 Å resolution even after extensive efforts. The geometry of the final model was validated with MolProbity 39 . Mutagenesis and kinetic assays. Site-specific and deletion mutations were introduced with the QuikChange kit (Agilent) and sequenced for confirmation. In deletion mutants, residues 940-972 of the a-helical hairpin (a8-a9) in domain AC1 and residues 836-918 in domain AC2 were replaced by a (GS) 3 linker, respectively, while residues 1902-1916 of the b4A-b4B loop in the C domain of CT were replaced by a (GS) 2 linker.
The catalytic activity of ACC was determined using a coupled enzyme assay, converting the hydrolysis of ATP to the disappearance of NADH 
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Extended Data Figure 9 | Comparisons of the structures of ACC central region alone with that in the holoenzyme. a, Overlay of AC1-AC2 in the holoenzyme (colour) with AC1-AC2 alone (yellow and grey). The first helix is swapped between two monomers in the structure of AC1-AC2 alone, and the two-fold axis of that dimer is indicated with the black line. b, Overlay of AC3-AC5 in the holoenzyme (colour) with AC3-AC5 alone (grey), based on AC3-AC4. A large difference is seen for the orientation of AC5. c, Overlay of BT-BCCP-AC1-AC5 in the holoenzyme (colour) with these domains alone (grey), based on AC1-AC2. Large differences are seen for BT, BCCP and AC3-AC5. d, Overlay of BT-BCCP-AC1-AC5 in the holoenzyme (colour) with these domains alone (grey), based on AC3-AC4. Large differences are seen for BT, BCCP and AC1-AC2, although AC5 has essentially the same position. RESEARCH LETTER
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